Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy

Douglas B. Johnson, Erika K. Wallender, Daniel N. Cohen, Sunaina S. Likhari, Jeffrey P. Zwerner, Jennifer G. Powers, Lisa Shinn, Mark C. Kelley, Richard W. Joseph, Jeffrey A. Sosman

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences